Literature DB >> 11251243

Design of nanoparticles composed of graft copolymers for oral peptide delivery.

S Sakuma1, M Hayashi, M Akashi.   

Abstract

The development of a dosage form that improves the absorption of peptide and protein drugs via the gastrointestinal tract is one of the greatest challenges in the pharmaceutical field. Many researchers have taken up the challenge, using approaches including mucoadhesive drug delivery, colon delivery, particulate drug delivery such as nanoparticles, microcapsules, liposomes, emulsions, micelles, and so on. The objective of this article is to provide the reader with outlines of novel nanoparticle technologies for oral peptide delivery based on polymer chemistry. The physicochemical properties of nanoparticles and their behavior on exposure to physiological media are greatly dominated by their chemical structures and surface characteristics. We will especially focus on the design of nanoparticles composed of novel graft copolymers having a hydrophobic backbone and hydrophilic branches as drug carriers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251243     DOI: 10.1016/s0169-409x(00)00119-8

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  19 in total

1.  Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.

Authors:  A K Bajpai; Jyoti Choubey
Journal:  J Mater Sci Mater Med       Date:  2006-04       Impact factor: 3.896

Review 2.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

3.  Formulation and evaluation of a salted-out isoniazid-loaded nanosystem.

Authors:  Lisa C du Toit; Viness Pillay; Yahya E Choonara; Sunny E Iyuke
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

4.  Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer.

Authors:  Hironori Kumagai; Wellington Pham; Makoto Kataoka; Ken-Ichiro Hiwatari; James McBride; Kevin J Wilson; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Eric H Liu; John C Gore; Shinji Sakuma
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

5.  Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.

Authors:  Ya Liu; Xiao Jie Cheng; Qi Feng Dang; Fang Kui Ma; Xi Guang Chen; Hyun Jin Park; Bum Keun Kim
Journal:  J Mater Sci Mater Med       Date:  2011-12-03       Impact factor: 3.896

6.  A potential of peanut agglutinin-immobilized fluorescent nanospheres as a safe candidate of diagnostic drugs for colonoscopy.

Authors:  Shinji Sakuma; Makoto Kataoka; Haruki Higashino; Takanori Yano; Yoshie Masaoka; Shinji Yamashita; Ken-Ichiro Hiwatari; Hiroyuki Tachikawa; Ryoji Kimura; Kunio Nakamura; Hironori Kumagai; John C Gore; Wellington Pham
Journal:  Eur J Pharm Sci       Date:  2011-01-07       Impact factor: 4.384

7.  Uptake and transport of novel amphiphilic polyelectrolyte-insulin nanocomplexes by Caco-2 cells--towards oral insulin.

Authors:  Colin Thompson; Woei Ping Cheng; Pramod Gadad; Karen Skene; Mhairi Smith; Gillian Smith; Alastair McKinnon; Rachel Knott
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

8.  Preparation and characterization of a novel smart polymeric hydrogel for drug delivery of insulin.

Authors:  Behzad Jafari; Farzaneh Rafie; Soodabeh Davaran
Journal:  Bioimpacts       Date:  2011-08-10

9.  PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat.

Authors:  V Bhardwaj; D D Ankola; S C Gupta; M Schneider; C-M Lehr; M N V Ravi Kumar
Journal:  Pharm Res       Date:  2009-09-09       Impact factor: 4.200

10.  Protein and Peptide drug delivery: oral approaches.

Authors:  Jessy Shaji; V Patole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.